Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2016-06-08 Remuneration Information
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
2016年度限制性股票激励计划（草案）实施考核管理办法
Remuneration Information Classification · 95% confidence The document is titled as a management method for the implementation and assessment of a restricted stock incentive plan for the year 2016 by Kunming Pharmaceutical Corporation. It details the purpose, principles, assessment objects, organizational structure, assessment period, indicators, methods, standards, and application of assessment results related to the stock incentive plan. There is no financial data, earnings information, or regulatory filing references. The content focuses on governance and management of the stock incentive plan, which is related to executive compensation and governance practices. It is not an announcement, report publication, or certification. Therefore, the document best fits the category of Remuneration Information, which covers reports detailing compensation and incentive plans for executives and directors.
2016-06-08 Chinese
董事会关于2015年授予股权激励所涉限制性股票解锁条件成就的说明
Board/Management Information Classification · 95% confidence The document is a statement from the board of directors regarding the fulfillment of conditions for unlocking restricted stock under a 2015 equity incentive plan. It references company law, securities law, stock exchange listing rules, and regulatory memorandums related to equity incentives. The content focuses on compliance with conditions for stock unlocking and the board's authorization for implementation. It is not a full financial report, audit report, or earnings release, nor is it a presentation or voting result. It is a formal board announcement about management and equity incentive matters, specifically about stock unlocking conditions. This fits best under Board/Management Information (MANG), as it relates to board decisions and management actions regarding equity incentives.
2016-06-08 Chinese
北京德恒（昆明）律师事务所关于昆药集团股份有限公司股权激励计划的法律意见书
Regulatory Filings
2016-06-08 Chinese
关于股东完成工商登记注销的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of shareholder registration cancellation and changes in shareholding due to a merger and cancellation of a company. It details the transfer of shares and the administrative approval for deregistration. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management discussion. The document is a regulatory announcement about shareholding changes and corporate actions, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS).
2016-06-08 Chinese
北京德恒（昆明）律师事务所关于股份有限公司2015年授予股权激励所涉限制性股票解锁事宜的法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the unlocking of restricted stock related to a 2015 equity incentive plan of a company. It references compliance with company law, securities law, and regulatory requirements, and confirms that the unlocking conditions have been met and necessary procedures followed. The document is not a financial report, audit report, or management report, nor is it an announcement of voting results or a regulatory filing in the usual sense. It is a standalone legal opinion related to a specific corporate action (stock unlocking under an equity incentive plan). This fits best under the category of Audit Report / Information (AR), as it is a legal opinion verifying compliance and conditions related to a corporate equity incentive event, which is a form of regulatory and compliance information but not a full annual report or financial statement. The document length is 2391 characters, which is short but contains substantive legal opinion rather than just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence.
2016-06-08 Chinese
八届五次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's supervisory board meeting (监事会决议公告). It details voting results on various internal company matters such as stock incentive plans and amendments to the company charter. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is not an announcement of voting results at a shareholder meeting but rather a supervisory board resolution announcement. Given the content and nature, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-06-08 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.